The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells
- 31 January 2004
- journal article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 92 (1), 65-72
- https://doi.org/10.1016/s1081-1206(10)61712-7
Abstract
Background Allergen-mediated mast cell activation is a key feature of ocular allergic diseases. Evidence of eosinophil-derived mediators in tears and conjunctival biopsy specimens has been associated with chronic ocular allergic inflammation. Objective To examine the role of conjunctival mast cell mediators in eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation. Methods Conjunctival cells were obtained by enzymatic digestion of cadaveric conjunctival tissues. Eosinophils were obtained from peripheral blood samples using negative magnetic bead selection. The effect of IgE-activated mast cell supernates on eosinophil degranulation and adherence to epithelial cells was compared with supernates obtained from mast cells pretreated with a degranulation inhibitor (olopatadine). Eosinophil adhesion was measured by eosinophil peroxidase assay, and eosinophil degranulation was measured by eosinophil-derived neurotoxin radioimmunoassay. Results IgE-activated conjunctival mast cell supernates stimulated adhesion of eosinophils to epithelial cells (20.4% ± 6.3% vs 3.1% ± 1.0%; P = .048). Degranulation was not required for this process (no effect of olopatadine). IgE-activated mast cell supernates stimulated eosinophil-derived neurotoxin release (108.89 ± 8.27 ng/10 6 cells vs 79.45 ± 5.21 ng/10 6 cells for controls, P = .02), which was significantly inhibited by pretreatment of mast cells with a degranulation inhibitor (79.22 ± 4.33 ng/10 6 cells vs 61.09 ± 5.39 ng/10 6 cells for olopatadine pretreated and untreated, respectively, P = .02). Conclusions Mediators released from conjunctival mast cells promote eosinophil adhesion to conjunctival epithelial cells and eosinophil degranulation. Degranulation inhibition studies suggest that different mast cell mediators are involved in regulation of these events.Keywords
This publication has 39 references indexed in Scilit:
- Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cellsAnnals of Allergy, Asthma & Immunology, 2001
- Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophilsAllergology International, 2001
- Olopatadine inhibits TNFα release from human conjunctival mast cellsAnnals of Allergy, Asthma & Immunology, 2000
- Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cellsClinical and Experimental Allergy, 2000
- Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitisAnnals of Allergy, Asthma & Immunology, 1999
- Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseasesJournal of Allergy and Clinical Immunology, 1998
- Eosinophil cationic protein in tears in allergic conjunctivitis.British Journal of Ophthalmology, 1996
- Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitisAllergy, 1995
- Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens.British Journal of Ophthalmology, 1992
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990